BTIG Maintains Buy Rating, Raises PT to $21 on Adaptive Biotechnologies.

viernes, 7 de noviembre de 2025, 5:03 am ET1 min de lectura
ADPT--

BTIG Maintains Buy Rating, Raises PT to $21 on Adaptive Biotechnologies.

BTIG Maintains Buy Rating, Raises PT to $21 on Adaptive Biotechnologies.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios